← Back to All Filings

Roivant Sciences Director Meghan FitzGerald Reports Tax Withholding Disposition

Low SignificanceSeptember 14, 2026 at 10:37:55 PM UTC

Roivant Sciences Ltd.

$ROIV4CIK: 0001635088

Subscribe to track ROIV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 4 Filing: Roivant Sciences Ltd. ($ROIV) Insider: Meghan FitzGerald (Director) Transaction: Net Settlement / Tax Withholding (Code F) Shares: 1,743 Common Shares @ $40.94 ($71,358.42) Post-Transaction Holdings: 41,220 shares Filing Date: 2026-09-14

Comprehensive Analysis

Executive Summary

On September 14, 2026, Roivant Sciences Ltd. ($ROIV) filed a Form 4 disclosing a transaction by Director Meghan FitzGerald. On September 10, 2026, 1,743 common shares were withheld by the issuer at a price of $40.94 per share (total value of $71,358.42) to satisfy tax withholding obligations arising from the vesting of equity awards granted under the Issuer's Non-Employee Director Compensation Plan.

Transaction Breakdown

  • Security: Common Shares
  • Transaction Code: F (Net settlement / tax withholding)
  • Shares Withheld: 1,743
  • Price per Share: $40.94
  • Total Value: $71,358.42
  • Ownership After Transaction: 41,220 direct shares

Significance

This transaction represents a routine disposition via tax withholding (Code F) rather than a discretionary open-market sale. As such, the trading significance is evaluated as Low.

Topics:#ROIV#RoivantSciences#Form4#InsiderTrading#BioTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.